Boyds
Boyd Consultants Limited is a global drug development consultancy established in 2005, headquartered in the UK with offices in Cheshire, Cambridgeshire, Dublin, and Pennsylvania. Specialising in translating cutting-edge science into medicinal products, Boyds provides Taranis with technical validation, regulatory affairs support, and due diligence services for portfolio company investments. With particular expertise in cell and gene therapies, biologicals, and orphan drugs—having been involved in the development of seven of the eight approved gene therapies globally—Boyds supports our portfolio companies through the full lifecycle from research to marketing approval. Their team of pharmaceutical physicians, regulatory specialists, and clinical operations experts helps ensure our invested companies can navigate international regulatory requirements whilst preparing comprehensive Saudi FDA submission strategies for successful localisation in the Kingdom.
